IRCCS National Neurological Institute "C. Mondino" Foundation
79
22
25
24
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 79 trials
100.0%
+13.5% vs industry average
1%
1 trials in Phase 3/4
0%
0 of 24 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (79)
A Pilot Study to Assess Optimal Prevention and Outcome Improvement in Young Ischemic Stroke
Role: lead
Spatiotemporal Entrainment Neuromodulation Targeting Cerebello-Cerebral Circuits to Enhance Cognitive and Social Rehabilitation in Cerebellar Diseases
Role: collaborator
Non-Invasive Brain Stimulation as Add-on Treatment in Chronic Migraine With Medication Overuse
Role: lead
RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment
Role: collaborator
Ditan Acute tReatments: Effectiveness and Tolerability (DART)
Role: collaborator
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
Role: collaborator
Gepant treAtments: EffectIveNess and tolERability (GAINER)
Role: collaborator
Innovative Treatments for Neurogenic Dysphagia
Role: lead
Ambroxol as a Disease-modifying Treatment in GBA-PD
Role: collaborator
Integrating AI in Postural Rehabilitation for Parkinson's Disease
Role: lead
Telerehabilitation With Digital Technologies for the Continuum of Care of Stroke Patients
Role: collaborator
Case-Finding for Neurocognitive Disorders in Pavia
Role: lead
Physical Activity on Neuroinflammation in Parkinson's Disease
Role: lead
Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine
Role: lead
Rehabilitation With and Without Robot and Allied Digital Technologies in Stroke Patients
Role: collaborator
Effect of Cognitive Behavioral Play Intervention and Epilepsy
Role: lead
Work-related Burden Changes, Quantified with HEADWORK, Among Individuals Treated with Migraine Preventive Therapies.
Role: lead
Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
Role: lead
Transition From Pediatric to Adult Epilepsy Care
Role: lead
Multiple Sclerosis and the Effects of Ketogenic Diet Therapy
Role: lead